Literature DB >> 2232481

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

G Remuzzi, T Bertani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2232481     DOI: 10.1038/ki.1990.217

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  47 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

2.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 3.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 4.  Renal failure and ACE inhibition: how much is too much?

Authors:  M-L Gross; M Adamczak; E Ritz
Journal:  Z Kardiol       Date:  2005-02

Review 5.  Chronic rejection and late renal allograft dysfunction.

Authors:  J Laine; C Holmberg; P Häyry
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

Review 6.  ACE inhibitors and proteinuria.

Authors:  R T Gansevoort; D de Zeeuw; P E de Jong
Journal:  Pharm World Sci       Date:  1996-12

7.  Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor.

Authors:  C Baylis
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

8.  Urine albumin-to-creatinine ratio is associated with the severity of liver disease, renal function and survival in patients with decompensated cirrhosis.

Authors:  Evangelos Cholongitas; Ioannis Goulis; Maria Ioannidou; Stergios Soulaidopoulos; Parthenis Chalevas; Evangelos Akriviadis
Journal:  Hepatol Int       Date:  2016-08-30       Impact factor: 6.047

Review 9.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Glomerular permselectivity in proteinuric patients after kidney transplantation.

Authors:  R Oberbauer; M Haas; H Regele; U Barnas; A Schmidt; G Mayer
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.